Cost analyses of remifentanil, mivacurium and ropivacaine – a systematic review

Author: Vassiliou Timon   Putzke Caroline   Geldner Götz   Eberhart Leopold  

Publisher: Informa Healthcare

ISSN: 1465-6566

Source: Expert Opinion on Pharmacotherapy, Vol.5, Iss.2, 2004-02, pp. : 415-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content